Sofiva Genomics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	76.54	112.08	96.81	119.81	214.99	188.85
Short-Term Investments	34.1	34.1	43.23	51.15	30.2	30.2
Cash & Short-Term Investments	110.64	146.18	140.03	170.96	245.19	219.05
Cash Growth	-18.76%	4.39%	-18.09%	-30.27%	11.94%	-10.58%
Accounts Receivable	62.2	65.94	75.95	75.16	74.04	62.32
Other Receivables	3.83	4.98	9.01	7.53	4.76	2.96
Receivables	66.03	70.92	84.96	82.68	78.8	65.28
Inventory	45.16	46.4	41.79	57.08	41.56	50.11
Prepaid Expenses	10.99	7.95	8.78	10.83	6.58	8.02
Other Current Assets	1.06	1.15	1.79	2.33	1.39	1.18
Total Current Assets	233.87	272.6	277.34	323.88	373.53	343.64
Property, Plant & Equipment	76.4	103.16	116.08	129.23	128.57	159.96
Long-Term Investments	381.18	368.02	348.09	333.32	297.35	229.74
Other Intangible Assets	7.42	8.19	6.86	6.61	6.23	3.78
Long-Term Deferred Tax Assets	4.72	5.06	9.31	6.65	8.91	8.58
Other Long-Term Assets	23.93	11.06	9.45	7.87	7.72	5.89
Total Assets	727.53	768.08	767.14	807.56	822.3	751.58
Accounts Payable	19.03	22.47	31.72	50.6	58.44	50.44
Accrued Expenses	23.47	33.1	37.15	36.48	30.52	31.01
Current Portion of Leases	13.83	16.43	14.43	14.16	14.48	15.45
Current Income Taxes Payable	0.96	-	-	-	4.22	-
Current Unearned Revenue	0.8	1.77	0.77	2.11	2.69	3.25
Other Current Liabilities	8.54	9.68	12.12	12.64	12.99	9.91
Total Current Liabilities	66.63	83.46	96.2	115.99	123.35	110.06
Long-Term Leases	25.13	36.95	49.15	60.52	71.45	85.65
Long-Term Deferred Tax Liabilities	0.16	0.24	0.25	0.62	-	0.02
Other Long-Term Liabilities	3.06	3.03	3.17	3.12	3.06	3.04
Total Liabilities	94.98	123.68	148.77	180.24	197.86	198.77
Common Stock	215.93	215.93	213.62	213.62	213.62	212.62
Additional Paid-In Capital	341.59	341.59	332.06	330.99	328.31	284.32
Retained Earnings	75.36	86.66	72.5	82.34	82.29	55.08
Comprehensive Income & Other	-0.13	-0.15	-0.05	-0.03	0.01	0.34
Total Common Equity	632.76	644.04	618.14	626.92	624.23	552.36
Minority Interest	-0.2	0.36	0.23	0.4	0.21	0.45
Shareholders' Equity	632.55	644.4	618.37	627.32	624.44	552.81
Total Liabilities & Equity	727.53	768.08	767.14	807.56	822.3	751.58
Total Debt	38.96	53.38	63.59	74.67	85.94	101.1
Net Cash (Debt)	71.67	92.8	76.45	96.29	159.26	117.95
Net Cash Growth	-8.98%	21.39%	-20.61%	-39.54%	35.02%	-15.32%
Net Cash Per Share	3.32	4.29	3.58	4.50	7.48	5.52
Filing Date Shares Outstanding	21.59	21.59	21.36	21.36	21.36	21.26
Total Common Shares Outstanding	21.59	21.59	21.36	21.36	21.36	21.26
Working Capital	167.25	189.14	181.14	207.89	250.18	233.58
Book Value Per Share	29.30	29.83	28.94	29.35	29.22	25.98
Tangible Book Value	625.33	635.85	611.28	620.3	618	548.58
Tangible Book Value Per Share	28.96	29.45	28.61	29.04	28.93	25.80
Machinery	146.81	167.48	157.43	144.6	115.73	107.69
Leasehold Improvements	28.02	28.15	28.33	29.91	29.33	29.55

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.